Entasis Therapeutics to Present at the 28th Annual Credit Suisse Healthcare Conference

20:00 EDT 28 Oct 2019 | Globe Newswire

WALTHAM, Mass., Oct. 29, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced that Dr. Michael Gutch, Chief Business Officer and Chief Financial Officer, will be hosting a fireside chat at the 28th Annual Credit Suisse Healthcare Conference being held November 11-13, 2019 in Scottsdale, AZ.

Details of the presentation are below:
Event: 28th Annual Credit Suisse Healthcare Conference 
Location:              The Phoenician
Date:   Tuesday, November 12, 2019
Time:     4:45 – 5:15 PM MST

Additionally, Dr. Gutch will hold 1-on-1 investor meetings at the conference. Investors attending the conference who are interested in meeting with Company management should contact their Credit Suisse representatives.

About Entasis
Entasis is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel antibacterial products to treat serious infections caused by multidrug-resistant Gram-negative bacteria. Entasis’ pathogen-targeted design platform has produced a pipeline of product candidates, including sulbactam-durlobactam (targeting Acinetobacter baumannii infections), zoliflodacin (targeting Neisseria gonorrhoeae), and ETX0282CPDP (targeting Enterobacteriaceae infections). Entasis is also using its platform to develop a novel class of antibiotics, non-β-lactam inhibitors of the penicillin-binding proteins (NBPs) (targeting Gram-negative infections). For more information, visit

Entasis Company Contact    
Kyle Dow
Entasis Therapeutics
(781) 810-0114

Investor Relations Contact
Tram Bui
The Ruth Group
(646) 536-7035

Media Contact
Kirsten Thomas
The Ruth Group
(508) 280-6592

Primary Logo


More From BioPortfolio on "Entasis Therapeutics to Present at the 28th Annual Credit Suisse Healthcare Conference"

Quick Search

Relevant Topics

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...